These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 8467510)
1. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Xing EP; Yang GY; Wang LD; Shi ST; Yang CS Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761 [TBL] [Abstract][Full Text] [Related]
3. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Huang Y; Boynton RF; Blount PL; Silverstein RJ; Yin J; Tong Y; McDaniel TK; Newkirk C; Resau JH; Sridhara R; Reid BJ; Meltzer SJ Cancer Res; 1992 Dec; 52(23):6525-30. PubMed ID: 1423299 [TBL] [Abstract][Full Text] [Related]
5. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033 [TBL] [Abstract][Full Text] [Related]
6. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Boynton RF; Huang Y; Blount PL; Reid BJ; Raskind WH; Haggitt RC; Newkirk C; Resau JH; Yin J; McDaniel T; Meltzer SJ Cancer Res; 1991 Oct; 51(20):5766-9. PubMed ID: 1913694 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985 [TBL] [Abstract][Full Text] [Related]
8. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China. Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219 [TBL] [Abstract][Full Text] [Related]
9. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
10. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Ruggeri B; Zhang SY; Caamano J; DiRado M; Flynn SD; Klein-Szanto AJ Oncogene; 1992 Aug; 7(8):1503-11. PubMed ID: 1630814 [TBL] [Abstract][Full Text] [Related]
11. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216 [TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785 [TBL] [Abstract][Full Text] [Related]
13. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. Sachse R; Murakami Y; Shiraishi M; Hayashi K; Sekiya T Oncogene; 1994 Jan; 9(1):39-47. PubMed ID: 8302602 [TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection. Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711 [TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226 [TBL] [Abstract][Full Text] [Related]
16. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641 [TBL] [Abstract][Full Text] [Related]
17. [Mutation and expression of Rb gene in human esophageal cancer]. Li HC Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):412-4. PubMed ID: 8200276 [TBL] [Abstract][Full Text] [Related]
18. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Murakami Y; Hayashi K; Hirohashi S; Sekiya T Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254 [TBL] [Abstract][Full Text] [Related]
19. The MTS1 gene is frequently mutated in primary human esophageal tumors. Zhou X; Tarmin L; Yin J; Jiang HY; Suzuki H; Rhyu MG; Abraham JM; Meltzer SJ Oncogene; 1994 Dec; 9(12):3737-41. PubMed ID: 7970734 [TBL] [Abstract][Full Text] [Related]
20. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]